In this review from Neurodegenerative Disease Management, explore current research into visual dysfunction in Alzheimer’s disease pathology.
Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.
The effects of microgravity on CSF could be responsible for the visual impairment intracranial pressure often seen in long-duration astronauts.
New research has identified how a subset of proteins associated with Alzheimer’s disease can enter and damage retinal cells, and could lead the way to future preventative and treatment strategies for age-related macular degeneration.
A comprehensive series of reviews, data and reports discussing how researchers may utilize the visual system to further understand the progression of MS has been presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress.
In this editorial, the author describes our current knowledge of eye movements and cognitive markers for diagnosis and prognosis in Alzheimer’s disease.
Neuronal preferences for the ‘strong eye’ in amblyopia causes alterations in brain connections.